These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 15813062)

  • 41. [Hypertension and arteriosclerosis].
    Sasamura H; Itoh H
    Nihon Rinsho; 2011 Jan; 69(1):125-30. PubMed ID: 21226272
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Therapeutic perspectives: association of ACE inhibitors and angiotensin receptor blockers].
    Costantino S; Millozzi F; Scarlata S
    Clin Ter; 2001; 152(2):77-8. PubMed ID: 11441526
    [No Abstract]   [Full Text] [Related]  

  • 43. The potential role of AT(1)-receptor blockade in the prevention and reversal of atherosclerosis.
    Papademetriou V
    J Hum Hypertens; 2002 Aug; 16 Suppl 3():S34-41. PubMed ID: 12140726
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Critical role for p47phox in renin-angiotensin system activation and blood pressure regulation.
    Grote K; Ortmann M; Salguero G; Doerries C; Landmesser U; Luchtefeld M; Brandes RP; Gwinner W; Tschernig T; Brabant EG; Klos A; Schaefer A; Drexler H; Schieffer B
    Cardiovasc Res; 2006 Aug; 71(3):596-605. PubMed ID: 16843452
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Non-antiarrhythmic pharmacological treatment of atrial fibrillation: focus on drugs acting on the renin-angiotensin system].
    Durin O; Pedrinazzi C; Inama G
    G Ital Cardiol (Rome); 2008 Oct; 9(10 Suppl 1):5S-10S. PubMed ID: 19195299
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Angiotensin II and atherosclerosis.
    Weiss D; Sorescu D; Taylor WR
    Am J Cardiol; 2001 Apr; 87(8A):25C-32C. PubMed ID: 11334765
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Angiotensin II and glomerulonephritis.
    Jardine AG
    J Hypertens; 1995 May; 13(5):487-93. PubMed ID: 7561004
    [No Abstract]   [Full Text] [Related]  

  • 48. Pharmacological strategies to prevent restenosis: lessons learned from blockade of the renin-angiotensin system.
    Pratt RE; Dzau VJ
    Circulation; 1996 Mar; 93(5):848-52. PubMed ID: 8598073
    [No Abstract]   [Full Text] [Related]  

  • 49. Clinical pathology and treatment of renin-angiotensin system 3. Atherosclerosis and the renin-angiotensin system.
    Matsubara H
    Intern Med; 2007; 46(16):1299-301. PubMed ID: 17704609
    [No Abstract]   [Full Text] [Related]  

  • 50. [Renin-angiotensin system and oxidative stress].
    Shimosawa T
    Nihon Rinsho; 2005 Mar; 63 Suppl 3():96-101. PubMed ID: 15813051
    [No Abstract]   [Full Text] [Related]  

  • 51. Angiotensin, fibrinolysis, and vascular homeostasis.
    Vaughan DE
    Am J Cardiol; 2001 Apr; 87(8A):18C-24C. PubMed ID: 11334764
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Angiotensin-converting enzyme inhibitors: are there credible mechanisms for beneficial effects in diabetic neuropathy?
    Malik RA; Tomlinson DR
    Int Rev Neurobiol; 2002; 50():415-30. PubMed ID: 12198819
    [No Abstract]   [Full Text] [Related]  

  • 53. [Oxidative stress].
    Kurabayashi M
    Nihon Rinsho; 2006 Jul; 64 Suppl 5():215-20. PubMed ID: 16895187
    [No Abstract]   [Full Text] [Related]  

  • 54. Angiotensin-II, the Brain, and Hypertension: An Update.
    Young CN; Davisson RL
    Hypertension; 2015 Nov; 66(5):920-6. PubMed ID: 26324508
    [No Abstract]   [Full Text] [Related]  

  • 55. [Renin-angiotensin system modulates vasoreactivity through a mechanism of oxidative stress].
    Ran HH; Zhang R
    Sheng Li Ke Xue Jin Zhan; 2011 Apr; 42(2):117-20. PubMed ID: 21770260
    [No Abstract]   [Full Text] [Related]  

  • 56. Oxidative stress produced by angiotensin too. Implications for hypertension and vascular injury.
    Oskarsson HJ; Heistad DD
    Circulation; 1997 Feb; 95(3):557-9. PubMed ID: 9024136
    [No Abstract]   [Full Text] [Related]  

  • 57. [Tissue renin-angiotensin system and ischemic heart diseases].
    Suzuki J; Higaki J; Horiuchi M
    Nihon Rinsho; 2003 May; 61 Suppl 5():837-42. PubMed ID: 12809042
    [No Abstract]   [Full Text] [Related]  

  • 58. Why we block angiotensin II.
    Meyer TW
    Kidney Int; 2000 Jul; 58(1):458-9. PubMed ID: 10886594
    [No Abstract]   [Full Text] [Related]  

  • 59. Linking oxidative stress, the renin-angiotensin system, and hypertension.
    Fanelli C; Zatz R
    Hypertension; 2011 Mar; 57(3):373-4. PubMed ID: 21282556
    [No Abstract]   [Full Text] [Related]  

  • 60. [Pathophysiological significance of RAS in formation of arteriosclerosis].
    Matsubara H; Yamada H; Tsubakimoto Y; Yokoi H
    Nihon Naika Gakkai Zasshi; 2006 Sep; 95(9):1762-8. PubMed ID: 17037312
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.